Manganese-based Superoxide Dismutase Mimics Modify Both Acute and Long-term Outcome Severity in a Drosophila Melanogaster Model of Classic Galactosemia
Overview
Authors
Affiliations
Aims: The goal of this study was to use two manganese (Mn)-based superoxide dismutase (SOD) mimics to test the hypothesis that reactive oxygen species contribute to both acute and long-term outcomes in a galactose-1P uridylyltransferase (GALT)-null Drosophila melanogaster model of classic galactosemia.
Results: We tested the impact of each of two Mn porphyrin SOD mimics, MnTnBuOE-2-PyP(5+), and MnTE-2-PyP(5+), (i) on survival of GALT-null Drosophila larvae reared in the presence versus absence of dietary galactose and (ii) on the severity of a long-term movement defect in GALT-null adult flies. Both SOD mimics conferred a significant survival benefit to GALT-null larvae exposed to galactose but not to controls or to GALT-null larvae reared in the absence of galactose. One mimic, MnTE-2-PyP(5+), also largely rescued a galactose-independent long-term movement defect otherwise seen in adult GALT-null flies. The survival benefit of both SOD mimics occurred despite continued accumulation of elevated galactose-1P in the treated animals, and studies of thiolated proteins demonstrated that in both the presence and absence of dietary galactose MnTE-2-PyP(5+) largely prevented the elevated protein oxidative damage otherwise seen in GALT-null animals relative to controls.
Innovation And Conclusions: Our results confirm oxidative stress as a mediator of acute galactose sensitivity in GALT-null Drosophila larvae and demonstrate for the first time that oxidative stress may also contribute to galactose-independent adult outcomes in GALT deficiency. Finally, our results demonstrate for the first time that both MnTnBuOE-2-PyP(5+) and MnTE-2-PyP(5+) are bioavailable and effective when administered through an oral route in a D. melanogaster model of classic galactosemia.
Reshaping the Treatment Landscape of a Galactose Metabolism Disorder.
Rubio-Gozalbo M, Naomi Vos E, Rivera I, Lai K, Berry G J Inherit Metab Dis. 2025; 48(2):e70013.
PMID: 39953772 PMC: 11829187. DOI: 10.1002/jimd.70013.
Mangini L, Lawrence R, Lopez M, Graham T, Bauer C, Nguyen H JIMD Rep. 2024; 65(4):280-294.
PMID: 38974607 PMC: 11224506. DOI: 10.1002/jmd2.12438.
Daenzer J, Druss J, Fridovich-Keil J J Inherit Metab Dis. 2024; 47(5):991-1000.
PMID: 38960603 PMC: 11563841. DOI: 10.1002/jimd.12774.
The hypergonadotropic hypogonadism conundrum of classic galactosemia.
Derks B, Rivera-Cruz G, Hagen-Lillevik S, Naomi Vos E, Demirbas D, Lai K Hum Reprod Update. 2022; 29(2):246-258.
PMID: 36512573 PMC: 9976963. DOI: 10.1093/humupd/dmac041.
Harnessing the Power of Purple Sweet Potato Color and -Inositol to Treat Classic Galactosemia.
Hagen-Lillevik S, Johnson J, Siddiqi A, Persinger J, Hale G, Lai K Int J Mol Sci. 2022; 23(15).
PMID: 35955788 PMC: 9369367. DOI: 10.3390/ijms23158654.